|
Volumn 142, Issue 49-50, 2000, Pages 65-66
|
Therapy with COX-2 inhibitors. Less risk--better tolerance;Therapie mit COX-2-Hemmern. Weniger Risiken--bessere Verträglichkeit.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELECOXIB;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
ARTICLE;
HUMAN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
PYRAZOLES;
SULFONAMIDES;
|
EID: 0034620064
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|